WHO tells a story “By April 1999, reports of 771 cases of substandard drugs had been entered into the WHO database on counterfeit drugs, 77% of which were from developing countries. (Data analysis showed that in 60% of the 325 cases for which detailed data were available, an active ingredient was lacking.)” Bad medicines don't just threaten lives; they undermine the entire medical system . What is being done? There are distinct aspects to deciphering and de-complexifying the counterfeit pharmaceutical supply chain. One that is probably more in use today by almost all pharmaceutical companies worldwide is the product-based tracking methodology which incorporates the use of high technology systems to identify counterfeit products in the market. These technologies include tamper-evident packaging, holographics, bar codes and the more recent RFID. Indian Scenario People buy two tablets and never a strip. The unique number idea doesn’t work here. Chemists know that t...
#MachineLearning, #BigData analytics, #ArtificialIntelligence have made the space of #digital #health even more interesting. Emerging markets like India are taking on these learning and bringing exciting business models. This blog is about Dr Dass's involvement in such projects and case studies. more on www.healthcursor.com